Patent cliffs & loss of exclusivity
Amgen is an American biotechnology company that develops, manufactures and sells medicines for cancer, heart disease, inflammatory conditions, rare diseases and other serious illnesses. It is also an investor in Quantinuum and a launch customer for its Helios quantum computer.
| Also Known As | Amgen Inc. |
|---|---|
| AngelList URL | https://angel.co/amgen |
| Apple App Store URL | https://apps.apple.com/us/developer/amgen-inc/id434433950 |
| Blog | https://www.amgenbiotechexperience.com/blog |
| CAGE Code | 0JVZ6 |
| Legal Name | Amgen Limited |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/amgen-2 |
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.